Biohaven Ltd. SEC filings BHVN

Biohaven Ltd. has 282 filings in SEC EDGAR's recent list, going back to Jul 1, 2022. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
10-Q Quarterly report May 4, 2026 Mar 31, 2026
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report Jul 31, 2023 Jun 30, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BHVN (NYSE)
Fiscal year ends
December 31
Incorporated in
Virgin Islands, British
Headquarters
New Haven, CT
SEC filer status
Large accelerated filer
SEC CIK
1935979
Former names
Biohaven Research Ltd. (until Sep 14, 2022)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.